Hi-Tech Pharmacal Enterprise Value:
351.67M for May 20, 2013Hi-Tech Pharmacal Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 20, 2013 | 351.67M |
| May 17, 2013 | 351.67M |
| May 16, 2013 | 340.41M |
| May 15, 2013 | 339.18M |
| May 14, 2013 | 353.16M |
| May 13, 2013 | 357.37M |
| May 10, 2013 | 368.36M |
| May 9, 2013 | 371.48M |
| May 8, 2013 | 379.36M |
| May 7, 2013 | 380.58M |
| May 6, 2013 | 355.20M |
| May 3, 2013 | 346.24M |
| May 2, 2013 | 346.51M |
| May 1, 2013 | 347.46M |
| April 30, 2013 | 362.39M |
| April 29, 2013 | 375.42M |
| April 26, 2013 | 370.13M |
| April 25, 2013 | 378.81M |
| April 24, 2013 | 373.38M |
| April 23, 2013 | 385.60M |
| April 22, 2013 | 369.72M |
| April 19, 2013 | 370.81M |
| April 18, 2013 | 366.33M |
| April 17, 2013 | 367.41M |
| April 16, 2013 | 368.91M |
| April 15, 2013 | 371.89M |
| April 12, 2013 | 391.16M |
| April 11, 2013 | 400.66M |
| April 10, 2013 | 394.15M |
| April 9, 2013 | 383.02M |
| April 8, 2013 | 379.63M |
| April 5, 2013 | 382.48M |
| April 4, 2013 | 388.31M |
| April 3, 2013 | 383.15M |
| April 2, 2013 | 383.29M |
| April 1, 2013 | 368.91M |
| March 28, 2013 | 363.07M |
| March 27, 2013 | 364.29M |
| March 26, 2013 | 373.38M |
| March 25, 2013 | 374.88M |
| March 22, 2013 | 388.58M |
| March 21, 2013 | 393.06M |
| March 20, 2013 | 390.21M |
| March 19, 2013 | 387.36M |
| March 18, 2013 | 387.23M |
| March 15, 2013 | 380.30M |
| March 14, 2013 | 381.53M |
| March 13, 2013 | 376.51M |
| March 12, 2013 | 381.26M |
| March 11, 2013 | 393.60M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
HITK Enterprise Value Benchmarks
| Companies | |
|---|---|
| Columbia Laboratories | 28.05M |
| SciClone Pharmaceuticals | 178.08M |
| Sagent Pharmaceuticals | 396.73M |
HITK Enterprise Value Rankings
| Overall |
65th percentile 2777 of 8002 |
| Sector |
59th percentile 263 of 650 in Healthcare |
| Industry |
56th percentile 28 of 65 in Drug Manufacturers - Specialty & Generic |
HITK Enterprise Value Range, Past 5 Years
| Minimum | 27.42M | Dec 3 2008 |
| Maximum | 478.90M | Jan 6 2012 |
| Average | 246.93M |
